These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26721621)

  • 1. Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets.
    Han SH; Park JC; Mook-Jung I
    Prog Neurobiol; 2016 Feb; 137():17-38. PubMed ID: 26721621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
    Barage SH; Sonawane KD
    Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer's Disease.
    Xia M; Cheng X; Yi R; Gao D; Xiong J
    Mol Neurobiol; 2016 Jan; 53(1):455-471. PubMed ID: 25465238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease.
    Catania M; Di Fede G; Tonoli E; Benussi L; Pasquali C; Giaccone G; Maderna E; Ghidoni R; Tagliavini F
    J Alzheimers Dis; 2015; 47(4):877-81. PubMed ID: 26401767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metals, membranes, and amyloid-β oligomers: key pieces in the Alzheimer's disease puzzle?
    Watt AD; Villemagne VL; Barnham KJ
    J Alzheimers Dis; 2013; 33 Suppl 1():S283-93. PubMed ID: 22699851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-free detection of ApoE4-mediated β-amyloid aggregation on single nanoparticle uncovering Alzheimer's disease.
    Kang MK; Lee J; Nguyen AH; Sim SJ
    Biosens Bioelectron; 2015 Oct; 72():197-204. PubMed ID: 25982728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential therapeutic implications of gelsolin in Alzheimer's disease.
    Ji L; Zhao X; Hua Z
    J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease.
    Martiskainen H; Haapasalo A; Kurkinen KM; Pihlajamäki J; Soininen H; Hiltunen M
    Expert Opin Ther Targets; 2013 Jul; 17(7):781-94. PubMed ID: 23573918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Androgens on the Amyloid-β Protein in Alzheimer's Disease.
    Lei Y; Renyuan Z
    Endocrinology; 2018 Dec; 159(12):3885-3894. PubMed ID: 30215697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the cause of sporadic Alzheimer's disease.
    Zetterberg H; Mattsson N
    Expert Rev Neurother; 2014 Jun; 14(6):621-30. PubMed ID: 24852227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction and Alzheimer's disease.
    Maruszak A; Żekanowski C
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody 9D5 recognizes oligomeric pyroglutamate amyloid-β in a fraction of amyloid-β deposits in Alzheimer's disease without cross-reactivity with other protein aggregates.
    Venkataramani V; Wirths O; Budka H; Härtig W; Kovacs GG; Bayer TA
    J Alzheimers Dis; 2012; 29(2):361-71. PubMed ID: 22232007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease.
    Sadowski MJ; Pankiewicz J; Scholtzova H; Mehta PD; Prelli F; Quartermain D; Wisniewski T
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18787-92. PubMed ID: 17116874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Eisele YS; Duyckaerts C
    Acta Neuropathol; 2016 Jan; 131(1):5-25. PubMed ID: 26715565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pin1, endothelial nitric oxide synthase, and amyloid-β form a feedback signaling loop involved in the pathogenesis of Alzheimer's disease, hypertension, and cerebral amyloid angiopathy.
    Wang JZ; Zhu WD; Xu ZX; Du WT; Zhang HY; Sun XW; Wang XH
    Med Hypotheses; 2014 Feb; 82(2):145-50. PubMed ID: 24332564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.